Products
Tropis
Stratis
Applications
Nucleic Acid Vaccines
COVID-19
Polio
Influenza
Resources
Press Coverage
News Releases
Publications
FAQs
Our Blogs
Events
About
About Pharmajet
Partnerships
Needle-free Technology
Contact
Publications
All Categories
Clinical Studies (28)
Pre-Clinical Studies (23)
All Tags
Adjuvants (1)
ANDV (3)
Arboviruses (10)
Atherosclerosis (1)
Cancer (3)
Clinical (2)
COVID-19 (8)
Cow (3)
Dengue (5)
DNA (24)
DOBV (1)
Equine Influenza (1)
Hamster (2)
Hantaviruses (5)
Hepatitis B (1)
HIV (1)
HNTV (1)
Horse (1)
HPV (1)
HTNV (1)
Improved Performance (14)
Inactivated (12)
Infectious Diseases (1)
Influenza (5)
Live Attenuated (7)
Lymphoma (1)
Mice (1)
MMR (3)
Mouse (2)
Nanoparticle (1)
Non-Human (1)
Non-Human Primate (10)
Other Applications (2)
Other Viruses (9)
Pentavalent (1)
Phase 1 (5)
Phase 1: Zika (1)
Phase 1/2 (2)
Phase 1/2: COVID-19 (1)
Phase 1b (1)
Phase 2 (2)
Phase 3/4 (1)
Phase 4 (3)
Phase III (1)
Pig (5)
Polio (9)
Pox (3)
Protein Subunit (2)
PRRSV (1)
PUUV (2)
Rabbit (4)
Rabies (2)
Respiratory Viruses (12)
RNA (3)
SEOV (1)
SNV (2)
Stratis (27)
Tropis (30)
Tropis/Stratis (7)
VEEV (2)
Zika (6)
Reset
Improved DNA Vaccine Delivery with Needle-Free Injection Systems
2023
Ledesma-Feliciano, C
Tags:
COVID-19
,
Dengue
,
DNA
,
Hantaviruses
,
HIV
,
Influenza
,
Pox
,
Tropis/Stratis
,
VEEV
,
Zika
View
A DNA vaccine targeting VEE virus delivered by needle-free jet-injection protects macaques against aerosol challenge
2022
Suschak, J
Tags:
Clinical
,
DNA
,
Infectious Diseases
,
Non-Human
,
Stratis
,
Tropis
,
VEEV
View
Efficacy, safety, and immunogenicity of the DNA SARS-CoV-2 vaccine (ZyCoV-D): the interim efficacy results of a phase 3, randomised, double-blind, placebo-controlled study in India
2022
Khobragade, A
Tags:
Clinical
,
DNA
,
Phase III
,
Respiratory Viruses
,
Tropis
View
Safety and immunogenicity of a ferritin nanoparticle H2 influenza vaccine in healthy adults: a phase 1 trial
2022
Houser, KV
Tags:
Improved Performance
,
Influenza
,
Phase 1
,
Stratis
View
Intradermal administration of fractional doses of the inactivated poliovirus vaccine in a campaign
2021
Bashorun, AO
Tags:
Inactivated
,
Polio
,
Tropis
View
Preclinical evaluation of a candidate naked plasmid DNA vaccine against SARS-CoV-2
2021
Lassaunière, R
Tags:
COVID-19
,
DNA
,
Improved Performance
,
Mice
,
Non-Human Primate
,
Rabbit
,
Stratis
View
Synthetic SARS-CoV-2 Spike-Based DNA Vaccine Elicits Robust and Long-Lasting Th1 Humoral and Cellular Immunity in Mice
2021
Alamri, SS
Tags:
COVID-19
,
DNA
,
Improved Performance
,
Mouse
,
Respiratory Viruses
,
Tropis
View
Cellular and Humoral Immunogenicity of a Candidate DNA Vaccine Expressing SARS-CoV-2 Spike Subunit 1
2021
Alluhaybi, KA
Tags:
COVID-19
,
DNA
,
Mouse
,
Respiratory Viruses
,
Tropis
View
Safety and Immunogenicity of a DNA SARS-CoV-2 vaccine (ZyCoV-D): Results of an open-label, non-randomized phase I part of phase I/II clinical study by intradermal route in healthy subjects in India
2021
Momin, T
Tags:
DNA
,
Improved Performance
,
Phase 1/2: COVID-19
,
Respiratory Viruses
,
Tropis
View
Immunogenic potential of DNA vaccine candidate, ZyCoV-D against SARS-CoV-2 in animal models
2021
Dey, A
Tags:
COVID-19
,
DNA
,
Rabbit
,
Respiratory Viruses
,
Stratis
View
Insulin-like growth factor I reduces atherosclerosis in Rapacz pigs
2021
Sukhanov
Tags:
Atherosclerosis
,
DNA
,
Other Applications
,
Pig
,
Stratis
View
Effective and Safe Stimulation of Humoral and Cell-Mediated Immunity by Intradermal Immunization with a Cyclic Dinucleotide/Nanoparticle Combination Adjuvant
2021
Hernandez-Franco, JF
Tags:
Adjuvants
,
Nanoparticle
,
Other Applications
,
Pig
,
Tropis
View
1
2
3
…
5
»
Menu